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Abstract 
Objective: People diagnosed with pancreatic cancer have the worst survival prognosis 
of any cancer. No previous research has documented the supportive care needs of this 
population. Our objective was to describe people’s needs and use of support services 
and to examine whether these differed according to whether or not patients had 
undergone surgical resection. 
 
Methods: Queensland pancreatic or ampullary cancer patients (n=136, 54% of those 
eligible) completed a survey which assessed 34 needs across 5 domains (SCNS-SF34) 
and use of health services. Differences by resection were compared with Chi-squared 
tests. 
 
Results: Overall, 96% of participants reported having some needs. More than half 
reported moderate-to-high unmet physical (54%) or psychological (52%) needs 
whereas, health system/information (32%), patient care (21%) and sexuality needs 
(16%) were described less frequently. The three most frequently reported moderate-to-
high needs included ‘not being able to do things they used to do’ (41%), ‘concerns 
about the worries of those close’ (37%), and ‘uncertainty about the future’ (30%). 
Patients with non-resectable disease reported greater individual information needs but 
their needs were otherwise similar to patients with resectable disease. Self-reported use 
of support was low; only 35% accessed information, 28%, 18% and 15% consulted a 
dietician, complementary medicine practitioner or mental health practitioner, 
respectively. Palliative care access was greater (59% vs 27%) among those with non-
resectable disease. 
 
Conclusion: Very high levels of needs were reported by people with pancreatic or 
ampullary cancer. Future work needs to elucidate why uptake of appropriate supportive 
care is low and which services are required. 
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Introduction 
 
Pancreatic cancer is the fifth leading cause of cancer death in more developed regions 
of the world [1]. People diagnosed with pancreatic cancer have the worst survival 
prognosis of any cancer; one-year survival is 20% and five-year survival is 6% [2]. 
Pancreatic and ampullary cancer have the same clinical presentation and are 
sometimes impossible to differentiate both clinically and on investigation. Ampullary 
cancers are treated similarly to pancreatic cancers, accounting for 16-50% of 
pancreaticoduodenectomies. The difficulty in differentiation and similarity in treatment 
means that they are often grouped [3]. From this point forward when referring to 
pancreatic cancer this will include ampullary cancer.  
 
The poor prognosis of pancreatic cancer is due to late presentation combined with 
aggressive tumour biology, complex surgery and no effective systemic treatments. The 
majority of patients (>60%) present with advanced disease and less than one-quarter 
have tumors that are amenable to resection [4]. Patients who have curative resection 
have low survival of 10-25% at five years [5]. Chemo- and radio-therapy options are 
available, but for most patients the survival benefit is small, with 5-year survival only 20-
25% following radical resection and adjuvant therapy [6]. Therefore a fundamental 
aspect of management for most patients will be supportive care and palliation of 
symptoms such as jaundice, cholangitis, diabetes, malabsorption, weight loss, nausea, 
vomiting, pain and depression [5].  
 
Multimodality supportive management including medical, allied health and palliative 
interventions should be initiated early and aggressively for all patients with pancreatic 
cancer [7-9]. This should happen regardless of whether they are progressing along a 
palliative or curative pathway [10] to facilitate adjustment to diagnosis, prognosis and 
treatment [9]. However, among patients with pancreatic cancer there is no quantitative 
research on the extent of supportive care needs or use of support services.   
 
One qualitative study of 12 pancreatic cancer patients and 23 caregivers identified 
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supportive care themes including management of gastrointestinal symptoms and 
complex dietary issues [11], with participants reporting insufficient information and 
dietician support. A case report highlighted the need for early referral to 
supportive/palliative care to achieve optimal symptom control [12].  
 
With the dearth of information about specific issues affecting the population of people 
with pancreatic cancer and uptake of support services, we conducted a population-
based study with the aim to determine the prevalence of unmet supportive care needs 
and whether these were different in those who did and did not have surgical resection. 
Resection was chosen for stratification as it is the only potentially curative treatment. 
We hypothesised that differences in needs could arise due to the difficult surgery with 
high co-morbidity or due to psychological differences relating to having versus not 
having a curative procedure. We also quantified the types of support services and 
providers that patients were accessing.   
 
Methods 
 
Participants and procedures 
Given the high early mortality associated with pancreatic cancer, the study used a rapid 
ascertainment approach, recruiting patients as early as possible through a state-wide 
network of clinicians in hospitals and private practices, often when diagnostic 
investigations were ongoing. Patients aged 18 years or over with a suspected or 
confirmed diagnosis of primary pancreatic cancer between January 2007 and June 
2011 were recruited for the Queensland Pancreatic Cancer Study (QPCS), a 
Queensland-wide, population-based case-control study [13]. Trained research nurses 
reviewed the medical records of all people recruited and 704 (84%) had a confirmed 
diagnosis of pancreatic cancer. A small number of patients with ampullary cancer were 
also enrolled. 
 
From July 2009 newly recruited QPCS participants were also invited to participate in a 
patient reported outcomes sub-study which involved completing a self-administered 
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questionnaire. Patients were given the information sheet, consent form, questionnaire 
and reply-paid envelope at the end of their QPCS interview where possible, or by mail 
soon after. Those who had not returned the questionnaire and consent form were 
followed-up by telephone after 10 and 17 days.  
 
Of the 351 QPCS participants with pancreatic or ampullary cancer recruited after July 
2009, 29 did not consent to being approached to participate in future studies, 8 died 
before they were able to be invited to participate, 10 were beyond the protocol 
timeframe of <10 months post-diagnosis and 50 were considered too unwell to 
approach by the research nurse.  
 
Of the 254 patients who were approached, 57 declined, 23 died shortly after receiving 
the questionnaire, 5 were lost to follow-up and 33 consented but did not return the 
questionnaire. The remaining 136 QPCS participants completed the patient reported 
outcomes questionnaire (54% of those approached), 13 of whom had ampullary cancer 
and were included as their exclusion did not alter the findings. Characteristics of 
participants were compared with those of the QPCS sample. 
 
The QPCS and patient reported outcomes sub-study were approved by the Human 
Research Ethics Committees of the QIMR Berghofer Medical Research Institute and 
participating hospitals. Participants provided written informed consent prior to 
participation. 
 
Measures 
Age, sex, marital status and education level were self-reported at recruitment into 
QPCS. Clinical information about cancer site, disease stage, surgery (resectable or 
non-resectable disease and bypass procedure), chemotherapy and palliative care 
consultation dates were extracted from medical records as part of the QPCS.  
 
The Supportive Care Needs Survey-Short Form (SCNS-SF34) was used to assess 
needs across five domains: psychological (10 items); physical/daily living (5 items); 
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health system/information (11 items); patient care/support (5 items); and sexuality (3 
items) [14]. This tool asks participants to rate their need for help with each item over the 
past month on a 5-point scale where 1 = not applicable (no need), 2 = satisfied (need 
was met), 3 = low unmet need, 4 = moderate unmet need, and 5 = high unmet need. As 
per the tool’s manual [15], the total scores for each domain were standardized (range 0 
to 100 where higher scores indicate higher levels of need) to allow direct comparison 
across need domains. Furthermore, two dichotomous need domain scores were 
classified: 1) no need versus any met-to-unmet domain-specific need and; 2) no-to-low 
need versus moderate-to-high domain-specific need. The SCNS-SF34 is a validated 
measure; its five domains collectively accounted for 73% of the total variance, with 
Cronbach’s alpha for domains ranging from 0.86 to 0.96 [14, 15].  
 
Service use was assessed using a tick box list which enabled participants to indicate 
whether they had accessed any of the following services: cancer helpline, tele-based 
cancer counselling, peer support, community-based support groups, internet-based 
support groups, information sheets, internet information, education program, chaplain, 
relaxation/meditation class, exercise physiologist, dietician, physiotherapist, social 
worker, psychologist, psychiatrist, mental health team, respite care, community health 
nurse, pain specialist, complementary medicine practitioner.  
 
Statistical methods  
Descriptive statistics were used to assess the level of supportive care needs and 
service use. Chi-squared tests, t-tests and Wilcoxon-Mann-Whitney tests were used to 
examine differences in the proportions of people reporting (a) any needs and (b) 
moderate-to-high needs between people who did and did not have a surgical resection.  
 
Results 
 
Participant characteristics 
The mean age of participants was 66 years, 60% were men, 79% had a partner, and 
74% had higher education (Table 1). These characteristics were proportionally the 
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same as those cases enrolled in the QPCS [13] and were similar within the groups who 
had or did not have a resection, with the exception of age where those who had a 
resection were significantly younger on average. 
 
At the time of completing the questionnaire, median time after diagnosis was 3 months, 
47% had late stage (stage III-IV) disease and 82% received chemotherapy (Table 1). 
Over half of the patients (56%) did not have a completed surgical resection either 
because they were not considered operable on the basis of staging investigations 
(39%), their age and/or comorbidities (5%) or because the resection was aborted due to 
the discovery of inoperable locally advanced disease (9%) or metastases (3%). One-
quarter of those with non-resectable disease had a bypass procedure to re-route the 
flow of bile, avoiding the pancreas, thus alleviating pain, problems with digestion, 
jaundice, and other symptoms that occur when the bile duct is blocked. This was a 
relatively well sample. In comparison, most pancreatic cancer patients treated in 
Queensland and New South Wales have late stage disease (67%), 10% receive 
adjuvant chemotherapy and 85% do not have a completed surgical resection [16]. 
 
Prevalence of needs within domains 
The median (M) standardised score was highest for physical/daily living needs (M=35; 
interquartile range [IQR] 15-60), followed by psychological, health system/information, 
and patient care (M=25 for each; IQR respectively 8-53, 18-35, 10-30) and lowest for 
sexuality needs (M=8; IQR 0-25). Overall, 96% of participants reported having some 
needs, both met and unmet, and 69% reported these to be at moderate-to-high unmet 
levels. More than 80% reported at least one met or unmet need in four of the five need 
domains and more than half reported a moderate-to-high unmet physical/daily living 
(54%) or psychological (52%) need. Furthermore, 32% and 21% of participants reported 
having a moderate-to-high unmet need for help with health system/information needs 
and patient care needs respectively. Fewer reported moderate-to-high level sexuality 
needs (16%). There were no statistically significant differences in needs between 
patients following a palliative or surgical resection pathway. 
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Most prevalent ‘moderate-to-high’ unmet need items 
The prevalences of moderate-to-high unmet need for individual items are shown in 
Table 2. The individual physical and psychological need items did not vary by whether 
the patient’s disease was resectable. However, patients with non-resectable disease 
were significantly more likely to report some health system/information needs (Table 2).  
 
Use of community and allied health services 
Table 3 shows the self-reported use of support services and palliative care as indicated 
in medical records. The most frequently used services (information and education) and 
providers (dieticians, complementary medicine practitioners and psychological 
practitioners) did not differ by resection. However, consultation with a physiotherapist or 
exercise physiologist was higher among participants who had a resection whereas 
participants with non-resectable disease were more likely to have accessed respite care 
(Table 3). Furthermore, palliative care access was significantly greater (59% vs 27%) 
amongst those who did not have a resection (Table 3).  
 
Psychological need for help and corresponding self-reported consultation with 
psychological health professionals 
Overall, 90% (n=121) of patients reported at least one psychological need. Of these, 3% 
(n=4) reported having all psychological needs satisfied, 76% (n=92) reported having at 
least one of their psychological needs satisfied, while only 16% (n=19) consulted a 
psychologist, psychiatrist, social worker or telephone counsellor (Figure 1).  
 
Discussion 
This population-based study shows that the levels of supportive care needs of people 
with pancreatic cancer are high, spanning multiple support domains and are generally 
similar between people with or without non-resectable disease. Over two-thirds of the 
participants reported at least one moderate-to-high level unmet need, the ten most 
prevalent of these were in the physical and psychological domains. The 
recommendations are for early and intensive initiation of supportive management for 
this patient cohort [10]. Our results suggest that this is not occurring sufficiently, either 
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due to lack of awareness and referral or the provided services being inadequate to meet 
the range of needs, or available services not being taken up by patients at sufficient 
rates.  
 
Our study found 4 out of the 5 need domains had median scores ≥25, while other 
studies using the same measures report fewer domains reaching this high level of need. 
A study of patients with solid tumours or haematological cancer reported 2 domains 
having scores ≥25 (physical/daily living and health system/information needs) [17] and 
studies of ovarian [18], breast [19] and similar aged colorectal cancer patients [20] 
found only one need domain ≥25 (psychological, health system/information & 
physical/daily living needs respectively). The lower levels of needs in these other patient 
groups are not unexpected given their overall better prognosis.  
 
The domain with greatest need reported by participants was physical/daily living needs. 
Needing help with lack of energy/tiredness, pain, feeling unwell and work around the 
home were unmet at moderate-to-high levels. With fatigue and pain significantly 
impairing quality of life, meeting these needs must be a priority [21]. Fatigue has been 
successfully managed with exercise in some cancer groups with early stage disease 
[22, 23], although this has not been investigated in patients with pancreatic cancer. Pain 
relief should involve a three-step "ladder" including prompt oral administration of non-
opioids (aspirin and paracetamol) followed by mild opioids (codeine) and then strong 
opioids (morphine) [24]. Celiac plexus neurolysis has achieved partial or complete pain 
relief in 70-90% of patients with pancreatic cancer [25]. While this and another study of 
patients with newly diagnosed pancreatic cancer [26] found one-quarter to one-third of 
patients have inadequate pain relief, it is uncertain from our data if this was due to 
inadequate diagnosis of pain, limited referral to services or inadequacy of pain control 
measures. This merits further research 
 
In people with pancreatic cancer, the contribution of pain to psychological distress has 
been recognised [26]. In this study, along with high levels of physical need almost all 
participants reported having a psychological need that was currently unmet by services; 
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half at moderate-to-high levels. Clinical practice guidelines [27] demonstrate strong 
evidence that end of life psychological interventions can improve mood, coping, sense 
of personal control, physical and functional adjustment. Psychosocial support programs 
for pancreatic cancer sufferers should address the priority unmet needs identified in this 
study, around family anxieties, uncertainty about the future, sense of personal control 
and positive adjustment. Our study, however, indicated that little psychological help was 
accessed and interestingly about two-thirds of people with some psychological needs 
had at least one, but not all, of their psychological needs satisfied without accessing 
professional support. These people may have utilised informal support from family and 
friends. Still, innovative, acceptable and convenient ways to provide evidenced-based 
psychological support deserve investigation. 
 
Our study also found that two-thirds of people with pancreatic cancer do not recall being 
provided with information about their cancer; in particular needs around managing 
illness and side-effects at home and explanations about tests were unmet in many 
patients with non-resectable disease. Universal information about medical treatments, 
side-effects, assistance for family members and addressing practical concerns was to 
be the base model of care applied in a community setting in Queensland Australia [28]. 
Our study suggests current provision is not meeting the end of life needs of this 
vulnerable population. How to improve the current information packages specific to 
pancreatic cancer may be a potential research topic. 
 
Integrated oncology–palliative care is one model of service delivery where palliative 
care teams assess and manage the full range of patients’ and families’ care needs 
across physical, psychological, social, spiritual, and information domains [29]. Early use 
of palliative care has been shown to lengthen survival [30], minimise physical and 
emotional symptoms and cost [29] and also minimise caregiver burden [31, 32]. While 
there were no differences in physical and emotional needs for patients who had or had 
not undergone resection, our results showed palliative care was largely reserved for 
people with advanced disease and, even then, only 59% of patients with advanced 
disease accessed palliative care services. One key barrier to early referral is the 
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perception that palliative care refers only to the end of life. Clinicians may feel that 
referral would destroy a patient’s and family’s hope [33] and some patients may refuse 
referral because of stigma and/or denial [34]. Using the term ‘supportive care’ rather 
than ‘palliative care’ might assuage some concerns [35]. Bruera and Hui further propose 
a theoretical framework that uses the analogy of a car to facilitate discussion around 
setting goals of care and early access to supportive/palliative care [12]. 
 
Although this is the largest population-based study of people with pancreatic cancer to 
date, it does have limitations. Firstly, the analysis was cross-sectional and included 
patients with wide variation in the time from diagnosis to questionnaire completion so it 
was not possible to determine temporal associations between access to services and 
supportive care needs. Secondly, our sample had a higher proportion of people with 
resectable disease than would be expected in the overall population [4]. It is therefore 
likely that we have under-estimated the level of unmet need in this patient group. Thirdly 
the measure of supportive care needs was validated for patients with a mix of 
prognoses thus there may be other important needs specific to palliation that are not 
identified here. 
 
In conclusion, this study has provided new information about the types and levels of 
supportive care needs specific to people with pancreatic cancer and about the health 
services that are being accessed. While rapid universal care of a range of support 
needs for this patient group is clearly necessary, the stark reality is that the current 
system is leaving many patients with unmet needs. Whether this is because of lack of 
needs assessment before management or lack of support service awareness remains 
unknown. Type of management (resectable vs non-resectable) did not alter the high 
levels of unmet physical and psychological needs. However, we found people with non-
resectable disease require clearer and more timely doctor-patient communication about 
their test results and how to manage their disease at home. Further research which 
explores how to better match available symptom management, psychological, education 
and specialist palliative care to all pancreatic cancer patients with high needs is 
paramount. 
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Table 1.Characteristics of participants with pancreatic or ampullary cancer by resection status 
 
 Overall (n=136) Resection/curative 
disease (n=60) 
No-
resection/palliative 
disease (n=76) 
p-
valuea 
 n  % n  % n  %  
Age (years), mean (SD) 66 (10) 62 (10) 69 (10) 0.001 
Gender        
Male 82 60 37 62 45 59 0.771 
Female 54 40 23 38 31 41  
Marital Status        
Married/Defacto 107 79 50 83 57 75 0.528 
Divorced/Separated  9 7 2 3 7 9  
Widowed 13 10 5 8 8 11  
Never married and no current partner 7 5 3 5 4 5  
Education        
11th grade or less  35 26 13 22 22 29 0.557 
12th grade or high school graduate  21 16 11 18 10 13  
Diploma/trade certificate  56 41 28 47 28 37  
University degree  23 17 8 13 15 20  
Months after diagnosis, median (range) 3 (0-9) 3 (1-8) 3 (1-9) 0.074 
Months after diagnosis        
0 - 3 83 61 32 53 51 67 0.225 
4 - 6 42 31 23 38 19 25  
7 - 9 11 8 5 8 6 8  
Cancer type        
Pancreatic cancer 123 90 49 82 74 97 0.002 
Ampullary cancer 13 10 11 18 2 3  
Disease Stage        
I 14 11 8 14 6 8 <0.001 
II 55 43 48 86 7 10  
III 16 13 0 0 16 23  
IV 43 34 0 0 42 59  
Months after resectionb, median (range) N/A 2 (1-7) N/A N/A 
Surgical resection        
Resection completed - curative disease 60 44 60 100 0 0 N/A 
Resection failed - locally advanced 
disease 
12 9 0 0 12 16  
Resection failed - metastatic disease 4 3 0 0 4 5  
No resection - locally advanced disease 15 11 0 0 15 20  
No resection – metastatic disease 38 28 0 0 38 50  
Resection not attempted due to age, 
and/or comorbidities 
 7  5 0 0 7 9  
Bypass procedure        
During failed resection 14 10 0 0 14 18  
Instead of resection  5 4 0 0 5 7 <0.001 
No bypass 117 86 60 100 57 75  
Chemotherapy        
No  20 15 4 7 16 21 0.051 
Currently on chemotherapy 106 78 50 83 56 74  
Had past chemotherapy 5 4 2 3 3 4  
Unknown 5 4 4 7 1 1  
a P-value (Chi-squared test for categorical variables, t-test for means and Wilcoxon-Mann-Whitney for medians) for 
difference between groups with or without resection  
b All questionnaires were completed after surgical resection 
SD - standard deviation
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Table 2.Top 20 moderate-to-high unmet supportive care needs reported by pancreatic or ampullary cancer patients  
Ranka Items Overall 
(n=136) 
Resection/curati
ve disease 
(n=60) 
No 
resection/palliativ
e disease (n=76) 
Domain  
1 Not being able to do things they used to do  41% 42% 39% Physical/daily living 
2 Concerns about the worries of those close  37% 32% 41% Psychological  
3  Uncertainty about the future  30% 27% 33% Psychological  
4 Lack of energy/tiredness 28% 25% 31% Physical/daily living 
4 Work around the home 28% 27% 30% Physical/daily living 
6 Fear about the cancer spreading  26% 28% 24% Psychological  
6 Pain  26% 20% 30% Physical/daily living 
8 Worry that the results of treatment are beyond your control 23% 19% 27% Psychological 
9 Learning to feel in control of your situation 21% 22% 21% Psychological 
9 Keeping a positive outlook 21% 23% 19% Psychological 
11 Feeling unwell a lot of the time 20% 18% 21% Physical/daily living 
12 Being informed about things you can do to help yourself to get well 19% 14% 23% Health system/information 
13 Having one member of hospital staff with whom you can talk to 
about all aspects of your condition, treatment and follow-up 
17% 14% 21% Health system/information 
13 Anxiety 17% 17% 17% Psychological 
15 Being given information (written, diagrams, drawings) about 
aspects of managing your illness and side-effects at home 
16% 9%* 22%* Health system/information 
15 Being given explanations of those tests for which you would like 
explanations 
16% 8%* 22%* Health system/information 
15 Having access to professional counselling(IE psychologist, social 
worker, counsellor, nurse specialist) if you, family or friends need it 
16% 14% 18% Health system/information 
18 Being informed about cancer which is under control or diminishing 
(that is, remission) 
15% 8% 20% Health system/information 
18 Feeling down or depressed 15% 17% 14% Psychological 
20 Being informed about your test results as soon as feasible 14% 5%* 22%* Health system/information 
aRanking based on overall proportion 
* Statistically significant difference (p<0.05, chi-squared) between groups with or without resection 
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Table 3. Pancreatic or ampullary cancer patients’ use of allied health and community support services 
Self-reported use up until the time of the survey Overall (n=136) Resection/curative 
disease (n=60) 
No resection/palliative 
disease (n=76) 
Information/education support (cancer helpline, information sheet, 
internet information, education program/workshop) 
35% 35% 34% 
Dietician 28% 35% 22% 
Complementary medical practitioner/relaxation/meditation class 18% 18% 17% 
Psychological support (psychiatrist, psychologist, social worker, 
telephone-based cancer counsellor)  
15% 18% 12% 
Peer support or community- or internet-based support group 14% 12% 16% 
Community health nurse 12% 10% 13% 
Pain specialist 7% 3% 9% 
Chaplain 7% 3% 9% 
Physiotherapist/exercise physiologist 4% 10%* 0%* 
Respite care 4% 0%* 7%* 
Palliative carea 45% 27%* 59%* 
* Statistically significant difference (p<0.05, chi squared) between groups with or without resection 
aMedical records indicates use before the time of the survey .   
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Figure 1.Psychological need burden and specialist consultation and satisfaction with care among pancreatic or ampullary cancer 
patients (n=136) 
Note: Accessed psychological support includes those who self-reported consulting a psychiatrist, psychologist, social worker or telephone-based cancer counsellor. 
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